Feng‐Rong Wang

5.0k total citations
219 papers, 3.1k citations indexed

About

Feng‐Rong Wang is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Feng‐Rong Wang has authored 219 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Hematology, 57 papers in Oncology and 44 papers in Immunology. Recurrent topics in Feng‐Rong Wang's work include Hematopoietic Stem Cell Transplantation (120 papers), Acute Myeloid Leukemia Research (59 papers) and Acute Lymphoblastic Leukemia research (37 papers). Feng‐Rong Wang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (120 papers), Acute Myeloid Leukemia Research (59 papers) and Acute Lymphoblastic Leukemia research (37 papers). Feng‐Rong Wang collaborates with scholars based in China, United States and Italy. Feng‐Rong Wang's co-authors include Xiao‐Jun Huang, Lan‐Ping Xu, Yu Wang, Kai‐Yan Liu, Yu‐Hong Chen, Xiaohui Zhang, Huan Chen, Chen‐Hua Yan, Xiao‐Dong Mo and Jingzhi Wang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Feng‐Rong Wang

199 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng‐Rong Wang China 28 2.1k 803 698 551 401 219 3.1k
Wei Han China 25 1.4k 0.7× 681 0.8× 520 0.7× 392 0.7× 328 0.8× 156 2.4k
Florent Malard France 32 2.1k 1.0× 946 1.2× 1.1k 1.6× 643 1.2× 1.0k 2.6× 145 3.6k
Grzegorz Basak Poland 30 1.7k 0.8× 735 0.9× 1.2k 1.7× 461 0.8× 880 2.2× 164 3.7k
Nathalie Dhédin France 29 1.4k 0.7× 823 1.0× 905 1.3× 352 0.6× 365 0.9× 127 3.2k
Rohtesh S. Mehta United States 22 925 0.4× 729 0.9× 669 1.0× 231 0.4× 335 0.8× 135 2.1k
Koji Kato Japan 34 2.2k 1.1× 713 0.9× 1.5k 2.1× 957 1.7× 584 1.5× 208 4.7k
Pedro Marı́n Spain 27 1.6k 0.8× 677 0.8× 814 1.2× 174 0.3× 381 1.0× 156 3.1k
U. Jehn Germany 24 1.1k 0.5× 429 0.5× 827 1.2× 451 0.8× 568 1.4× 125 2.7k
Thomas Luft Germany 34 1.5k 0.8× 2.3k 2.8× 894 1.3× 288 0.5× 925 2.3× 127 4.5k
Kyungja Han South Korea 26 637 0.3× 379 0.5× 401 0.6× 261 0.5× 710 1.8× 158 2.4k

Countries citing papers authored by Feng‐Rong Wang

Since Specialization
Citations

This map shows the geographic impact of Feng‐Rong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Rong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Rong Wang more than expected).

Fields of papers citing papers by Feng‐Rong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Rong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Rong Wang. The network helps show where Feng‐Rong Wang may publish in the future.

Co-authorship network of co-authors of Feng‐Rong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Rong Wang. A scholar is included among the top collaborators of Feng‐Rong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Rong Wang. Feng‐Rong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ólafsson, Einar B., et al.. (2025). Metabolic adaptability and nutrient scavenging in Toxoplasma gondii : insights from ingestion pathway-deficient mutants. mSphere. 10(4). e0101124–e0101124. 1 indexed citations
2.
Ren, Juan, Jiangtao Li, Xiaodan Liu, et al.. (2025). Tandem Versus Single Autologous Stem Cell Transplantation for High‐Risk Multiple Myeloma in the Era of Novel Agents: A Real‐World Study of China. Cancer Medicine. 14(1). e70573–e70573. 1 indexed citations
3.
Zhao, Chen, M. Xiao, Feng Zhang, et al.. (2025). Outcomes and prognostic factors associated with relapse after haploidentical stem cell transplantation for paediatric T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 206(4). 1165–1172.
4.
Zhou, Jianying, Xiaolu Zhu, Yun He, et al.. (2024). A prognostic score system in adult T‐cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 59(4). 496–504. 2 indexed citations
7.
Zhang, Xiaohui, Lan‐Ping Xu, Yu Wang, et al.. (2023). Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study. 1(1). 100009–100009. 8 indexed citations
8.
Fu, Hai‐Xia, Meng Lv, Huixin Liu, et al.. (2023). Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation. Bone Marrow Transplantation. 58(12). 1368–1376. 1 indexed citations
10.
Wang, Feng‐Rong, Shihua Zhao, Yajun Li, et al.. (2023). Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study. Annals of Hematology. 102(11). 3185–3193.
11.
Yang, Liping, Peng Zhao, Yejun Wu, et al.. (2022). Treatment outcome and efficacy of therapeutic plasma exchange for transplant-associated thrombotic microangiopathy in a large real-world cohort study. Bone Marrow Transplantation. 57(4). 554–561. 7 indexed citations
12.
Chen, Qi, Xin Zhao, Hai‐Xia Fu, et al.. (2020). Posterior reversible encephalopathy syndrome (PRES) after haploidentical haematopoietic stem cell transplantation: incidence, risk factors and outcomes. Bone Marrow Transplantation. 55(10). 2035–2042. 10 indexed citations
13.
Kannan, Geetha, Manlio Di Cristina, Feng‐Rong Wang, et al.. (2019). Role of Toxoplasma gondii Chloroquine Resistance Transporter in Bradyzoite Viability and Digestive Vacuole Maintenance. mBio. 10(4). 17 indexed citations
14.
Mo, Xiao‐Dong, Xiaohui Zhang, Lan‐Ping Xu, et al.. (2015). Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 21(11). 1939–1947. 46 indexed citations
15.
Xu, Zhengli, Xiao‐Jun Huang, Yuqian Sun, et al.. (2015). [Cytomegalovirus specific cytotoxic T lymphocytes for treatment of refractory cytomegalovirus infection in patients following allogeneic hematopoietic stem cell transplantation].. PubMed. 54(2). 101–5. 5 indexed citations
16.
Wang, Feng‐Rong, et al.. (2015). Skin Keratins. Methods in enzymology on CD-ROM/Methods in enzymology. 568. 303–350. 47 indexed citations
17.
Wang, Feng‐Rong. (2013). The Role of Heart Kidney Yang Deficiency in Chronic Heart Failure. 1 indexed citations
18.
Chen, Yao, Xiao‐Jun Huang, Feng‐Rong Wang, et al.. (2012). [Etiological analysis of fever in the first 24 hours following allogeneic peripheral stem cell transfusion].. PubMed. 51(3). 179–83. 4 indexed citations
19.
Hossain, Mohammad Salim, John D. Roback, Feng‐Rong Wang, & Edmund K. Waller. (2008). Host and Donor Immune Responses Contribute to Antiviral Effects of Amotosalen-Treated Donor Lymphocytes following Early Posttransplant Cytomegalovirus Infection. The Journal of Immunology. 180(10). 6892–6902. 11 indexed citations
20.
Liu, Yanli, Xuemin Li, Guoliang Jin, et al.. (2003). [HPV detection and FHIT expression in esophageal squamous carcinoma from high incidence area in Cixian County].. PubMed. 22(5). 492–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026